Shugeng Gao
Cancer Hospital Chinese Academy of Medical Science
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Haichuan Su, PhD
Tang-Du Hospital
Shared therapeutic areas:
Jiang Fan, MD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shared therapeutic areas:
Luis Rojas, MD
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Shared therapeutic areas:
Liu Wei, MD
Hebei Provincal Tumor Hospital
Shared therapeutic areas:
Worked with same sponsors:
Xiaohua Hu, MD
First Affiliated Hospital of Guangxi Medical University
Shared therapeutic areas:
Worked with same sponsors:
Fang Jian, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Worked with same sponsors:
Nong Yang, MD
Hunan Cancer Hospital
Shared therapeutic areas:
Jiao Shunchang, MD
Chinese People's Liberation Army (PLA) General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Petros Christopoulos, MD
University Hospital Heidelberg
Shared therapeutic areas:
Daniel Tan, BSc, MBBS, PhD
National Cancer Centre Singapore (Lead Sponsor)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer
Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer
All 2 trials loaded